PEDIATRIA_PERU : Mensaje: The Lancet: Top 20 most downloaded articles*

	Find us on Facebook Follow us on Twitter


Top 20 most downloaded articles*
The Lancet is renowned the world over for publishing groundbreaking medical research. The latest Impact Factor of 30.76 is our best yet - and we endeavour to build on this reputation every day by publishing world class content. Your peers recognize the value of this content and we have highlighted below the top 20 downloaded articles so far this year. All article abstracts can be viewed free of charge by clicking on the links below. However full-text access is available for only $31.50 per article. This entitles you to 24 hour access and during this period you can download and store a PDF of the article for future use at no extra charge. *Via TheLancet.com in 2010 to date

1. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
|FULL TEXT|

2. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
|FULL TEXT|

3. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
|FULL TEXT|

4. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial
|FULL TEXT|

5. Biological, clinical, and ethical advances of placebo effects
|FULL TEXT|

6. Clinical assessment incorporating a personal genome
|FULL TEXT|

7. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial
|FULL TEXT|

8. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
|FULL TEXT|

9. Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial
|FULL TEXT|

10. Ticagrelor in ACS: redefining a new standard of care?
|FULL TEXT|

11. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial
|FULL TEXT|

12. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
|FULL TEXT|

13. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
|FULL TEXT|

14. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension
|FULL TEXT|

15. Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
|FULL TEXT|

16. Ageing populations: the challenges ahead
|FULL TEXT|

17. Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials
|FULL TEXT|

18. Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial
|FULL TEXT|

19. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
|FULL TEXT|

20. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
|FULL TEXT|

Alternatively for the price of less than 4 articles, subscribe to The Lancet via TheLancet.com and access all of the content above as well our online archive dating back to 1996. All for just 75% of the normal price. Click here >>>

You are receiving this email because you are a registered user on TheLancet.com and opted in to receive related information from TheLancet.com . This email has been sent from The Lancet, Elsevier Limited, The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, registered in England with registered number 1982084.

To update your profile, click here , log in with your username and password, and amend your preferences. If you are unable to remember your log-in details, you can unsubscribe by clicking here .

Forgotten your password? Click here - for a reminder.

Copyright © 2010 Elsevier Limited. All rights reserved. Please read our site's Privacy Policy .

THE LANCET ® is a registered trademark of Elsevier Properties SA, used under license.

WILLIAM ARELLANO
Pediatra
facebook.com/William.Virgo.
RPM: #893353
Cel: 964 713855

Información del grupo

Consejos de Yahoo! Grupos

¿Sabías que...?

Mensajes